APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diagnostic Radioisotopes

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Diagnostic Radioisotopes Market Analysis and Forecast 2026-2032

20 December 2025199 pages

Choose your research edition.

Industry ResearchDiagnostic Radioisotopes Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Diagnostic Radioisotopes Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Diagnostic Radioisotopes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diagnostic Radioisotopes Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Diagnostic Radioisotopes Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Diagnostic Radioisotopes market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Diagnostic Radioisotopes is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Diagnostic Radioisotopes is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Diagnostic Radioisotopes is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Diagnostic Radioisotopes is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Diagnostic Radioisotopes include China Isotope & Radiation, Novartis, Eli Lilly, Dongcheng, SIEMENS, Lantheus, Jubilant Pharma, GE Healthcare and Curium Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Diagnostic Radioisotopes, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Diagnostic Radioisotopes, also provides the sales of main regions and countries. Of the upcoming market potential for Diagnostic Radioisotopes, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Diagnostic Radioisotopes sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Diagnostic Radioisotopes market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Diagnostic Radioisotopes sales, projected growth trends, production technology, application and end-user industry.

Diagnostic Radioisotopes Segment by Company

China Isotope & Radiation

Novartis

Eli Lilly

Dongcheng

SIEMENS

Lantheus

Jubilant Pharma

GE Healthcare

Curium Pharma

Cardinal Health

Bracco Imaging

Diagnostic Radioisotopes Segment by Type

Tc-99m

F-18

Other

Diagnostic Radioisotopes Segment by Application

Oncology

Cardiology

Other

Diagnostic Radioisotopes Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diagnostic Radioisotopes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diagnostic Radioisotopes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diagnostic Radioisotopes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Diagnostic Radioisotopes in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Diagnostic Radioisotopes manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diagnostic Radioisotopes sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Diagnostic Radioisotopes Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tc-99m Major Manufacturers Table 3. F-18 Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Diagnostic Radioisotopes Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Oncology Major Manufacturers Table 7. Cardiology Major Manufacturers Table 8. Other Major Manufacturers Table 9. Diagnostic Radioisotopes Industry Trends Table 10. Diagnostic Radioisotopes Industry Drivers Table 11. Diagnostic Radioisotopes Industry Opportunities and Challenges Table 12. Diagnostic Radioisotopes Industry Restraints Table 13. Global Diagnostic Radioisotopes Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Diagnostic Radioisotopes Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Diagnostic Radioisotopes Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Diagnostic Radioisotopes Revenue Market Share by Region (2021-2026) Table 17. Global Diagnostic Radioisotopes Revenue Market Share by Region (2027-2032) Table 18. Global Diagnostic Radioisotopes Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Diagnostic Radioisotopes Sales by Region (2021-2026) & (k units) Table 20. Global Diagnostic Radioisotopes Sales by Region (2027-2032) & (k units) Table 21. Global Diagnostic Radioisotopes Sales Market Share by Region (2021-2026) Table 22. Global Diagnostic Radioisotopes Sales Market Share by Region (2027-2032) Table 23. Global Diagnostic Radioisotopes Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Diagnostic Radioisotopes Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Diagnostic Radioisotopes Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Diagnostic Radioisotopes Sales Market Share by Manufacturers (2021-2026) Table 27. Global Diagnostic Radioisotopes Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Diagnostic Radioisotopes Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Diagnostic Radioisotopes Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Diagnostic Radioisotopes Manufacturers, Product Type & Application Table 31. Global Diagnostic Radioisotopes Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Diagnostic Radioisotopes by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Diagnostic Radioisotopes Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Diagnostic Radioisotopes Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Diagnostic Radioisotopes Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Diagnostic Radioisotopes Revenue Market Share by Type (2021-2026) Table 38. Global Diagnostic Radioisotopes Revenue Market Share by Type (2027-2032) Table 39. Global Diagnostic Radioisotopes Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Diagnostic Radioisotopes Sales by Type (2021-2026) & (k units) Table 41. Global Diagnostic Radioisotopes Sales by Type (2027-2032) & (k units) Table 42. Global Diagnostic Radioisotopes Sales Market Share by Type (2021-2026) Table 43. Global Diagnostic Radioisotopes Sales Market Share by Type (2027-2032) Table 44. Global Diagnostic Radioisotopes Price by Type (2021-2026) & (US$/unit) Table 45. Global Diagnostic Radioisotopes Price by Type (2027-2032) & (US$/unit) Table 46. Global Diagnostic Radioisotopes Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Diagnostic Radioisotopes Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Diagnostic Radioisotopes Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Diagnostic Radioisotopes Revenue Market Share by Application (2021-2026) Table 50. Global Diagnostic Radioisotopes Revenue Market Share by Application (2027-2032) Table 51. Global Diagnostic Radioisotopes Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Diagnostic Radioisotopes Sales by Application (2021-2026) & (k units) Table 53. Global Diagnostic Radioisotopes Sales by Application (2027-2032) & (k units) Table 54. Global Diagnostic Radioisotopes Sales Market Share by Application (2021-2026) Table 55. Global Diagnostic Radioisotopes Sales Market Share by Application (2027-2032) Table 56. Global Diagnostic Radioisotopes Price by Application (2021-2026) & (US$/unit) Table 57. Global Diagnostic Radioisotopes Price by Application (2027-2032) & (US$/unit) Table 58. China Isotope & Radiation Company Information Table 59. China Isotope & Radiation Business Overview Table 60. China Isotope & Radiation Diagnostic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. China Isotope & Radiation Diagnostic Radioisotopes Product Portfolio Table 62. China Isotope & Radiation Recent Development Table 63. Novartis Company Information Table 64. Novartis Business Overview Table 65. Novartis Diagnostic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Novartis Diagnostic Radioisotopes Product Portfolio Table 67. Novartis Recent Development Table 68. Eli Lilly Company Information Table 69. Eli Lilly Business Overview Table 70. Eli Lilly Diagnostic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Eli Lilly Diagnostic Radioisotopes Product Portfolio Table 72. Eli Lilly Recent Development Table 73. Dongcheng Company Information Table 74. Dongcheng Business Overview Table 75. Dongcheng Diagnostic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Dongcheng Diagnostic Radioisotopes Product Portfolio Table 77. Dongcheng Recent Development Table 78. SIEMENS Company Information Table 79. SIEMENS Business Overview Table 80. SIEMENS Diagnostic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. SIEMENS Diagnostic Radioisotopes Product Portfolio Table 82. SIEMENS Recent Development Table 83. Lantheus Company Information Table 84. Lantheus Business Overview Table 85. Lantheus Diagnostic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Lantheus Diagnostic Radioisotopes Product Portfolio Table 87. Lantheus Recent Development Table 88. Jubilant Pharma Company Information Table 89. Jubilant Pharma Business Overview Table 90. Jubilant Pharma Diagnostic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Jubilant Pharma Diagnostic Radioisotopes Product Portfolio Table 92. Jubilant Pharma Recent Development Table 93. GE Healthcare Company Information Table 94. GE Healthcare Business Overview Table 95. GE Healthcare Diagnostic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. GE Healthcare Diagnostic Radioisotopes Product Portfolio Table 97. GE Healthcare Recent Development Table 98. Curium Pharma Company Information Table 99. Curium Pharma Business Overview Table 100. Curium Pharma Diagnostic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Curium Pharma Diagnostic Radioisotopes Product Portfolio Table 102. Curium Pharma Recent Development Table 103. Cardinal Health Company Information Table 104. Cardinal Health Business Overview Table 105. Cardinal Health Diagnostic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Cardinal Health Diagnostic Radioisotopes Product Portfolio Table 107. Cardinal Health Recent Development Table 108. Bracco Imaging Company Information Table 109. Bracco Imaging Business Overview Table 110. Bracco Imaging Diagnostic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Bracco Imaging Diagnostic Radioisotopes Product Portfolio Table 112. Bracco Imaging Recent Development Table 113. North America Diagnostic Radioisotopes Revenue by Type (2021-2026) & (US$ Million) Table 114. North America Diagnostic Radioisotopes Revenue by Type (2027-2032) & (US$ Million) Table 115. North America Diagnostic Radioisotopes Sales by Type (2021-2026) & (k units) Table 116. North America Diagnostic Radioisotopes Sales by Type (2027-2032) & (k units) Table 117. North America Diagnostic Radioisotopes Sales Price by Type (2021-2026) & (US$/unit) Table 118. North America Diagnostic Radioisotopes Sales Price by Type (2027-2032) & (US$/unit) Table 119. North America Diagnostic Radioisotopes Revenue by Application (2021-2026) & (US$ Million) Table 120. North America Diagnostic Radioisotopes Revenue by Application (2027-2032) & (US$ Million) Table 121. North America Diagnostic Radioisotopes Sales by Application (2021-2026) & (k units) Table 122. North America Diagnostic Radioisotopes Sales by Application (2027-2032) & (k units) Table 123. North America Diagnostic Radioisotopes Sales Price by Application (2021-2026) & (US$/unit) Table 124. North America Diagnostic Radioisotopes Sales Price by Application (2027-2032) & (US$/unit) Table 125. North America Diagnostic Radioisotopes Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America Diagnostic Radioisotopes Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 127. North America Diagnostic Radioisotopes Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 128. North America Diagnostic Radioisotopes Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 129. North America Diagnostic Radioisotopes Sales by Country (2021-2026) & (k units) Table 130. North America Diagnostic Radioisotopes Sales by Country (2027-2032) & (k units) Table 131. North America Diagnostic Radioisotopes Sales Price by Country (2021-2026) & (US$/unit) Table 132. North America Diagnostic Radioisotopes Sales Price by Country (2027-2032) & (US$/unit) Table 133. United States Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 134. Canada Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 135. Mexico Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 136. Europe Diagnostic Radioisotopes Revenue by Type (2021-2026) & (US$ Million) Table 137. Europe Diagnostic Radioisotopes Revenue by Type (2027-2032) & (US$ Million) Table 138. Europe Diagnostic Radioisotopes Sales by Type (2021-2026) & (k units) Table 139. Europe Diagnostic Radioisotopes Sales by Type (2027-2032) & (k units) Table 140. Europe Diagnostic Radioisotopes Sales Price by Type (2021-2026) & (US$/unit) Table 141. Europe Diagnostic Radioisotopes Sales Price by Type (2027-2032) & (US$/unit) Table 142. Europe Diagnostic Radioisotopes Revenue by Application (2021-2026) & (US$ Million) Table 143. Europe Diagnostic Radioisotopes Revenue by Application (2027-2032) & (US$ Million) Table 144. Europe Diagnostic Radioisotopes Sales by Application (2021-2026) & (k units) Table 145. Europe Diagnostic Radioisotopes Sales by Application (2027-2032) & (k units) Table 146. Europe Diagnostic Radioisotopes Sales Price by Application (2021-2026) & (US$/unit) Table 147. Europe Diagnostic Radioisotopes Sales Price by Application (2027-2032) & (US$/unit) Table 148. Europe Diagnostic Radioisotopes Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Europe Diagnostic Radioisotopes Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 150. Europe Diagnostic Radioisotopes Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 151. Europe Diagnostic Radioisotopes Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 152. Europe Diagnostic Radioisotopes Sales by Country (2021-2026) & (k units) Table 153. Europe Diagnostic Radioisotopes Sales by Country (2027-2032) & (k units) Table 154. Europe Diagnostic Radioisotopes Sales Price by Country (2021-2026) & (US$/unit) Table 155. Europe Diagnostic Radioisotopes Sales Price by Country (2027-2032) & (US$/unit) Table 156. Germany Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 157. France Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 158. U.K. Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 159. Italy Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 160. Russia Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 161. Spain Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 162. Netherlands Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 163. Switzerland Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 164. Sweden Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 165. Poland Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 166. China Diagnostic Radioisotopes Revenue by Type (2021-2026) & (US$ Million) Table 167. China Diagnostic Radioisotopes Revenue by Type (2027-2032) & (US$ Million) Table 168. China Diagnostic Radioisotopes Sales by Type (2021-2026) & (k units) Table 169. China Diagnostic Radioisotopes Sales by Type (2027-2032) & (k units) Table 170. China Diagnostic Radioisotopes Sales Price by Type (2021-2026) & (US$/unit) Table 171. China Diagnostic Radioisotopes Sales Price by Type (2027-2032) & (US$/unit) Table 172. China Diagnostic Radioisotopes Revenue by Application (2021-2026) & (US$ Million) Table 173. China Diagnostic Radioisotopes Revenue by Application (2027-2032) & (US$ Million) Table 174. China Diagnostic Radioisotopes Sales by Application (2021-2026) & (k units) Table 175. China Diagnostic Radioisotopes Sales by Application (2027-2032) & (k units) Table 176. China Diagnostic Radioisotopes Sales Price by Application (2021-2026) & (US$/unit) Table 177. China Diagnostic Radioisotopes Sales Price by Application (2027-2032) & (US$/unit) Table 178. Asia Diagnostic Radioisotopes Revenue by Type (2021-2026) & (US$ Million) Table 179. Asia Diagnostic Radioisotopes Revenue by Type (2027-2032) & (US$ Million) Table 180. Asia Diagnostic Radioisotopes Sales by Type (2021-2026) & (k units) Table 181. Asia Diagnostic Radioisotopes Sales by Type (2027-2032) & (k units) Table 182. Asia Diagnostic Radioisotopes Sales Price by Type (2021-2026) & (US$/unit) Table 183. Asia Diagnostic Radioisotopes Sales Price by Type (2027-2032) & (US$/unit) Table 184. Asia Diagnostic Radioisotopes Revenue by Application (2021-2026) & (US$ Million) Table 185. Asia Diagnostic Radioisotopes Revenue by Application (2027-2032) & (US$ Million) Table 186. Asia Diagnostic Radioisotopes Sales by Application (2021-2026) & (k units) Table 187. Asia Diagnostic Radioisotopes Sales by Application (2027-2032) & (k units) Table 188. Asia Diagnostic Radioisotopes Sales Price by Application (2021-2026) & (US$/unit) Table 189. Asia Diagnostic Radioisotopes Sales Price by Application (2027-2032) & (US$/unit) Table 190. Asia Diagnostic Radioisotopes Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. Asia Diagnostic Radioisotopes Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. Asia Diagnostic Radioisotopes Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. Asia Diagnostic Radioisotopes Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 194. Asia Diagnostic Radioisotopes Sales by Country (2021-2026) & (k units) Table 195. Asia Diagnostic Radioisotopes Sales by Country (2027-2032) & (k units) Table 196. Asia Diagnostic Radioisotopes Sales Price by Country (2021-2026) & (US$/unit) Table 197. Asia Diagnostic Radioisotopes Sales Price by Country (2027-2032) & (US$/unit) Table 198. Japan Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 199. South Korea Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 200. India Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 201. Australia Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 202. Taiwan Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 203. Southeast Asia Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 204. SAMEA Diagnostic Radioisotopes Revenue by Type (2021-2026) & (US$ Million) Table 205. SAMEA Diagnostic Radioisotopes Revenue by Type (2027-2032) & (US$ Million) Table 206. SAMEA Diagnostic Radioisotopes Sales by Type (2021-2026) & (k units) Table 207. SAMEA Diagnostic Radioisotopes Sales by Type (2027-2032) & (k units) Table 208. SAMEA Diagnostic Radioisotopes Sales Price by Type (2021-2026) & (US$/unit) Table 209. SAMEA Diagnostic Radioisotopes Sales Price by Type (2027-2032) & (US$/unit) Table 210. SAMEA Diagnostic Radioisotopes Revenue by Application (2021-2026) & (US$ Million) Table 211. SAMEA Diagnostic Radioisotopes Revenue by Application (2027-2032) & (US$ Million) Table 212. SAMEA Diagnostic Radioisotopes Sales by Application (2021-2026) & (k units) Table 213. SAMEA Diagnostic Radioisotopes Sales by Application (2027-2032) & (k units) Table 214. SAMEA Diagnostic Radioisotopes Sales Price by Application (2021-2026) & (US$/unit) Table 215. SAMEA Diagnostic Radioisotopes Sales Price by Application (2027-2032) & (US$/unit) Table 216. SAMEA Diagnostic Radioisotopes Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 217. SAMEA Diagnostic Radioisotopes Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 218. SAMEA Diagnostic Radioisotopes Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 219. SAMEA Diagnostic Radioisotopes Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 220. SAMEA Diagnostic Radioisotopes Sales by Country (2021-2026) & (k units) Table 221. SAMEA Diagnostic Radioisotopes Sales by Country (2027-2032) & (k units) Table 222. SAMEA Diagnostic Radioisotopes Sales Price by Country (2021-2026) & (US$/unit) Table 223. SAMEA Diagnostic Radioisotopes Sales Price by Country (2027-2032) & (US$/unit) Table 224. Brazil Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 225. Argentina Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 226. Chile Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 227. Colombia Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 228. Peru Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 229. Saudi Arabia Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 230. Israel Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 231. UAE Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 232. Turkey Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 233. Iran Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 234. Egypt Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 235. Key Raw Materials Table 236. Raw Materials Key Suppliers Table 237. Diagnostic Radioisotopes Distributors List Table 238. Diagnostic Radioisotopes Customers List Table 239. Research Programs/Design for This Report Table 240. Authors List of This Report Table 241. Secondary Sources Table 242. Primary Sources List of Figures Figure 1. Diagnostic Radioisotopes Image Figure 2. Global Diagnostic Radioisotopes Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diagnostic Radioisotopes Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tc-99m Image Figure 5. F-18 Image Figure 6. Other Image Figure 7. Global Diagnostic Radioisotopes Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Diagnostic Radioisotopes Market Size Share 2021 VS 2025 VS 2032 Figure 9. Oncology Image Figure 10. Cardiology Image Figure 11. Other Image Figure 12. Global Diagnostic Radioisotopes Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Diagnostic Radioisotopes Revenue (2021-2032) & (US$ Million) Figure 14. Global Diagnostic Radioisotopes Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Diagnostic Radioisotopes Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Diagnostic Radioisotopes Revenue Market Share by Region (2021-2032) Figure 17. Global Diagnostic Radioisotopes Sales (2021-2032) & (k units) Figure 18. Global Diagnostic Radioisotopes Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Diagnostic Radioisotopes Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Diagnostic Radioisotopes Sales YoY (2021-2032) & (k units) Figure 21. Europe Diagnostic Radioisotopes Sales YoY (2021-2032) & (k units) Figure 22. China Diagnostic Radioisotopes Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Diagnostic Radioisotopes Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Diagnostic Radioisotopes Sales YoY (2021-2032) & (k units) Figure 25. Global Diagnostic Radioisotopes Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Diagnostic Radioisotopes Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Diagnostic Radioisotopes Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Diagnostic Radioisotopes Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Diagnostic Radioisotopes Revenue Market Share by Type (2021-2032) Figure 31. Global Diagnostic Radioisotopes Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Diagnostic Radioisotopes Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Diagnostic Radioisotopes Sales Market Share by Type (2021-2032) Figure 34. Global Diagnostic Radioisotopes Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Diagnostic Radioisotopes Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Diagnostic Radioisotopes Revenue Market Share by Application (2021-2032) Figure 37. Global Diagnostic Radioisotopes Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Diagnostic Radioisotopes Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Diagnostic Radioisotopes Sales Market Share by Application (2021-2032) Figure 40. North America Diagnostic Radioisotopes Revenue Share by Type (2021-2032) Figure 41. North America Diagnostic Radioisotopes Sales Share by Type (2021-2032) Figure 42. North America Diagnostic Radioisotopes Revenue Share by Application (2021-2032) Figure 43. North America Diagnostic Radioisotopes Sales Share by Application (2021-2032) Figure 44. North America Diagnostic Radioisotopes Revenue Share by Country (2021-2032) Figure 45. North America Diagnostic Radioisotopes Sales Share by Country (2021-2032) Figure 46. Europe Diagnostic Radioisotopes Revenue Share by Type (2021-2032) Figure 47. Europe Diagnostic Radioisotopes Sales Share by Type (2021-2032) Figure 48. Europe Diagnostic Radioisotopes Revenue Share by Application (2021-2032) Figure 49. Europe Diagnostic Radioisotopes Sales Share by Application (2021-2032) Figure 50. Europe Diagnostic Radioisotopes Revenue Share by Country (2021-2032) Figure 51. Europe Diagnostic Radioisotopes Sales Share by Country (2021-2032) Figure 52. China Diagnostic Radioisotopes Revenue Share by Type (2021-2032) Figure 53. China Diagnostic Radioisotopes Sales Share by Type (2021-2032) Figure 54. China Diagnostic Radioisotopes Revenue Share by Application (2021-2032) Figure 55. China Diagnostic Radioisotopes Sales Share by Application (2021-2032) Figure 56. Asia Diagnostic Radioisotopes Revenue Share by Type (2021-2032) Figure 57. Asia Diagnostic Radioisotopes Sales Share by Type (2021-2032) Figure 58. Asia Diagnostic Radioisotopes Revenue Share by Application (2021-2032) Figure 59. Asia Diagnostic Radioisotopes Sales Share by Application (2021-2032) Figure 60. Asia Diagnostic Radioisotopes Revenue Share by Country (2021-2032) Figure 61. Asia Diagnostic Radioisotopes Sales Share by Country (2021-2032) Figure 62. SAMEA Diagnostic Radioisotopes Revenue Share by Type (2021-2032) Figure 63. SAMEA Diagnostic Radioisotopes Sales Share by Type (2021-2032) Figure 64. SAMEA Diagnostic Radioisotopes Revenue Share by Application (2021-2032) Figure 65. SAMEA Diagnostic Radioisotopes Sales Share by Application (2021-2032) Figure 66. SAMEA Diagnostic Radioisotopes Revenue Share by Country (2021-2032) Figure 67. SAMEA Diagnostic Radioisotopes Sales Share by Country (2021-2032) Figure 68. Diagnostic Radioisotopes Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Diagnostic Radioisotopes Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Tc-99m
  • F-18
  • Other
Applications
  • Oncology
  • Cardiology
  • Other
Companies covered
  • China Isotope & Radiation
  • Novartis
  • Eli Lilly
  • Dongcheng
  • SIEMENS
  • Lantheus
  • Jubilant Pharma
  • GE Healthcare
  • Curium Pharma
  • Cardinal Health
  • Bracco Imaging

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Diagnostic Radioisotopes Market by Type
  3. 1.2.1 Global Diagnostic Radioisotopes Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tc-99m
  5. 1.2.3 F-18
  6. 1.2.4 Other
  7. 1.3 Diagnostic Radioisotopes Market by Application
  8. 1.3.1 Global Diagnostic Radioisotopes Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Oncology
  10. 1.3.3 Cardiology
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Diagnostic Radioisotopes Market Dynamics
  1. 2.1 Diagnostic Radioisotopes Industry Trends
  2. 2.2 Diagnostic Radioisotopes Industry Drivers
  3. 2.3 Diagnostic Radioisotopes Industry Opportunities and Challenges
  4. 2.4 Diagnostic Radioisotopes Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Diagnostic Radioisotopes Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Diagnostic Radioisotopes Revenue by Region
  3. 3.2.1 Global Diagnostic Radioisotopes Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Diagnostic Radioisotopes Revenue by Region (2021-2026)
  5. 3.2.3 Global Diagnostic Radioisotopes Revenue by Region (2027-2032)
  6. 3.2.4 Global Diagnostic Radioisotopes Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Diagnostic Radioisotopes Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Diagnostic Radioisotopes Sales by Region
  9. 3.4.1 Global Diagnostic Radioisotopes Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Diagnostic Radioisotopes Sales by Region (2021-2026)
  11. 3.4.3 Global Diagnostic Radioisotopes Sales by Region (2027-2032)
  12. 3.4.4 Global Diagnostic Radioisotopes Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Diagnostic Radioisotopes Revenue by Manufacturers
  2. 4.1.1 Global Diagnostic Radioisotopes Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Diagnostic Radioisotopes Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Diagnostic Radioisotopes Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Diagnostic Radioisotopes Sales by Manufacturers
  6. 4.2.1 Global Diagnostic Radioisotopes Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Diagnostic Radioisotopes Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Diagnostic Radioisotopes Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Diagnostic Radioisotopes Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Diagnostic Radioisotopes Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Diagnostic Radioisotopes Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Diagnostic Radioisotopes Manufacturers, Product Type & Application
  13. 4.7 Global Diagnostic Radioisotopes Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Diagnostic Radioisotopes Market CR5 and HHI
  16. 4.8.2 2025 Diagnostic Radioisotopes Tier 1, Tier 2, and Tier 3
5 Diagnostic Radioisotopes Market by Type
  1. 5.1 Global Diagnostic Radioisotopes Revenue by Type
  2. 5.1.1 Global Diagnostic Radioisotopes Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Diagnostic Radioisotopes Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Diagnostic Radioisotopes Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Diagnostic Radioisotopes Sales by Type
  6. 5.2.1 Global Diagnostic Radioisotopes Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Diagnostic Radioisotopes Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Diagnostic Radioisotopes Sales Market Share by Type (2021-2032)
  9. 5.3 Global Diagnostic Radioisotopes Price by Type
6 Diagnostic Radioisotopes Market by Application
  1. 6.1 Global Diagnostic Radioisotopes Revenue by Application
  2. 6.1.1 Global Diagnostic Radioisotopes Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Diagnostic Radioisotopes Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Diagnostic Radioisotopes Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Diagnostic Radioisotopes Sales by Application
  6. 6.2.1 Global Diagnostic Radioisotopes Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Diagnostic Radioisotopes Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Diagnostic Radioisotopes Sales Market Share by Application (2021-2032)
  9. 6.3 Global Diagnostic Radioisotopes Price by Application
7 Company Profiles
  1. 7.1 China Isotope & Radiation
  2. 7.1.1 China Isotope & Radiation Company Information
  3. 7.1.2 China Isotope & Radiation Business Overview
  4. 7.1.3 China Isotope & Radiation Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 China Isotope & Radiation Diagnostic Radioisotopes Product Portfolio
  6. 7.1.5 China Isotope & Radiation Recent Developments
  7. 7.2 Novartis
  8. 7.2.1 Novartis Company Information
  9. 7.2.2 Novartis Business Overview
  10. 7.2.3 Novartis Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novartis Diagnostic Radioisotopes Product Portfolio
  12. 7.2.5 Novartis Recent Developments
  13. 7.3 Eli Lilly
  14. 7.3.1 Eli Lilly Company Information
  15. 7.3.2 Eli Lilly Business Overview
  16. 7.3.3 Eli Lilly Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Eli Lilly Diagnostic Radioisotopes Product Portfolio
  18. 7.3.5 Eli Lilly Recent Developments
  19. 7.4 Dongcheng
  20. 7.4.1 Dongcheng Company Information
  21. 7.4.2 Dongcheng Business Overview
  22. 7.4.3 Dongcheng Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Dongcheng Diagnostic Radioisotopes Product Portfolio
  24. 7.4.5 Dongcheng Recent Developments
  25. 7.5 SIEMENS
  26. 7.5.1 SIEMENS Company Information
  27. 7.5.2 SIEMENS Business Overview
  28. 7.5.3 SIEMENS Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 SIEMENS Diagnostic Radioisotopes Product Portfolio
  30. 7.5.5 SIEMENS Recent Developments
  31. 7.6 Lantheus
  32. 7.6.1 Lantheus Company Information
  33. 7.6.2 Lantheus Business Overview
  34. 7.6.3 Lantheus Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Lantheus Diagnostic Radioisotopes Product Portfolio
  36. 7.6.5 Lantheus Recent Developments
  37. 7.7 Jubilant Pharma
  38. 7.7.1 Jubilant Pharma Company Information
  39. 7.7.2 Jubilant Pharma Business Overview
  40. 7.7.3 Jubilant Pharma Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Jubilant Pharma Diagnostic Radioisotopes Product Portfolio
  42. 7.7.5 Jubilant Pharma Recent Developments
  43. 7.8 GE Healthcare
  44. 7.8.1 GE Healthcare Company Information
  45. 7.8.2 GE Healthcare Business Overview
  46. 7.8.3 GE Healthcare Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 GE Healthcare Diagnostic Radioisotopes Product Portfolio
  48. 7.8.5 GE Healthcare Recent Developments
  49. 7.9 Curium Pharma
  50. 7.9.1 Curium Pharma Company Information
  51. 7.9.2 Curium Pharma Business Overview
  52. 7.9.3 Curium Pharma Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Curium Pharma Diagnostic Radioisotopes Product Portfolio
  54. 7.9.5 Curium Pharma Recent Developments
  55. 7.10 Cardinal Health
  56. 7.10.1 Cardinal Health Company Information
  57. 7.10.2 Cardinal Health Business Overview
  58. 7.10.3 Cardinal Health Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Cardinal Health Diagnostic Radioisotopes Product Portfolio
  60. 7.10.5 Cardinal Health Recent Developments
  61. 7.11 Bracco Imaging
  62. 7.11.1 Bracco Imaging Company Information
  63. 7.11.2 Bracco Imaging Business Overview
  64. 7.11.3 Bracco Imaging Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Bracco Imaging Diagnostic Radioisotopes Product Portfolio
  66. 7.11.5 Bracco Imaging Recent Developments
8 North America
  1. 8.1 North America Diagnostic Radioisotopes Market Size by Type
  2. 8.1.1 North America Diagnostic Radioisotopes Revenue by Type (2021-2032)
  3. 8.1.2 North America Diagnostic Radioisotopes Sales by Type (2021-2032)
  4. 8.1.3 North America Diagnostic Radioisotopes Price by Type (2021-2032)
  5. 8.2 North America Diagnostic Radioisotopes Market Size by Application
  6. 8.2.1 North America Diagnostic Radioisotopes Revenue by Application (2021-2032)
  7. 8.2.2 North America Diagnostic Radioisotopes Sales by Application (2021-2032)
  8. 8.2.3 North America Diagnostic Radioisotopes Price by Application (2021-2032)
  9. 8.3 North America Diagnostic Radioisotopes Market Size by Country
  10. 8.3.1 North America Diagnostic Radioisotopes Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Diagnostic Radioisotopes Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Diagnostic Radioisotopes Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Diagnostic Radioisotopes Market Size by Type
  2. 9.1.1 Europe Diagnostic Radioisotopes Revenue by Type (2021-2032)
  3. 9.1.2 Europe Diagnostic Radioisotopes Sales by Type (2021-2032)
  4. 9.1.3 Europe Diagnostic Radioisotopes Price by Type (2021-2032)
  5. 9.2 Europe Diagnostic Radioisotopes Market Size by Application
  6. 9.2.1 Europe Diagnostic Radioisotopes Revenue by Application (2021-2032)
  7. 9.2.2 Europe Diagnostic Radioisotopes Sales by Application (2021-2032)
  8. 9.2.3 Europe Diagnostic Radioisotopes Price by Application (2021-2032)
  9. 9.3 Europe Diagnostic Radioisotopes Market Size by Country
  10. 9.3.1 Europe Diagnostic Radioisotopes Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Diagnostic Radioisotopes Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Diagnostic Radioisotopes Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Diagnostic Radioisotopes Market Size by Type
  2. 10.1.1 China Diagnostic Radioisotopes Revenue by Type (2021-2032)
  3. 10.1.2 China Diagnostic Radioisotopes Sales by Type (2021-2032)
  4. 10.1.3 China Diagnostic Radioisotopes Price by Type (2021-2032)
  5. 10.2 China Diagnostic Radioisotopes Market Size by Application
  6. 10.2.1 China Diagnostic Radioisotopes Revenue by Application (2021-2032)
  7. 10.2.2 China Diagnostic Radioisotopes Sales by Application (2021-2032)
  8. 10.2.3 China Diagnostic Radioisotopes Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Diagnostic Radioisotopes Market Size by Type
  2. 11.1.1 Asia Diagnostic Radioisotopes Revenue by Type (2021-2032)
  3. 11.1.2 Asia Diagnostic Radioisotopes Sales by Type (2021-2032)
  4. 11.1.3 Asia Diagnostic Radioisotopes Price by Type (2021-2032)
  5. 11.2 Asia Diagnostic Radioisotopes Market Size by Application
  6. 11.2.1 Asia Diagnostic Radioisotopes Revenue by Application (2021-2032)
  7. 11.2.2 Asia Diagnostic Radioisotopes Sales by Application (2021-2032)
  8. 11.2.3 Asia Diagnostic Radioisotopes Price by Application (2021-2032)
  9. 11.3 Asia Diagnostic Radioisotopes Market Size by Country
  10. 11.3.1 Asia Diagnostic Radioisotopes Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Diagnostic Radioisotopes Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Diagnostic Radioisotopes Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Diagnostic Radioisotopes Market Size by Type
  2. 12.1.1 SAMEA Diagnostic Radioisotopes Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Diagnostic Radioisotopes Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Diagnostic Radioisotopes Price by Type (2021-2032)
  5. 12.2 SAMEA Diagnostic Radioisotopes Market Size by Application
  6. 12.2.1 SAMEA Diagnostic Radioisotopes Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Diagnostic Radioisotopes Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Diagnostic Radioisotopes Price by Application (2021-2032)
  9. 12.3 SAMEA Diagnostic Radioisotopes Market Size by Country
  10. 12.3.1 SAMEA Diagnostic Radioisotopes Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Diagnostic Radioisotopes Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Diagnostic Radioisotopes Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Diagnostic Radioisotopes Value Chain Analysis
  2. 13.1.1 Diagnostic Radioisotopes Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Diagnostic Radioisotopes Production Mode & Process
  6. 13.2 Diagnostic Radioisotopes Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Diagnostic Radioisotopes Distributors
  9. 13.2.3 Diagnostic Radioisotopes Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst